Cargando…

Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2

Detalles Bibliográficos
Autores principales:	Chen, Shanmei, Feng, Junnan, Zhao, Chuanke, Wang, Lixin, Meng, Lin, Liu, Caiyun, Cai, Shaoqing, Jia, Yanxing, Qu, Like, Shou, Chengchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642386/ https://www.ncbi.nlm.nih.gov/pubmed/34862391 http://dx.doi.org/10.1038/s41392-021-00739-5

Ejemplares similares

Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2022)

Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion
por: Liu, Caiyun, et al.
Publicado: (2018)

Sarsaparilla (Smilax Glabra Rhizome) Extract Inhibits Migration and Invasion of Cancer Cells by Suppressing TGF-β1 Pathway
por: She, Tiantian, et al.
Publicado: (2015)

Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis
por: Zhao, Chuanke, et al.
Publicado: (2015)

Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
por: Zheng, Yutian, et al.
Publicado: (2023)

Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy
por: Feng, Junnan, et al.
Publicado: (2018)

N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells
por: Yuan, Shiqin, et al.
Publicado: (2016)

Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783
por: Tian, Wei, et al.
Publicado: (2012)

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
por: Liu, Jiafei, et al.
Publicado: (2019)

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
por: Mu, Xianmin, et al.
Publicado: (2012)

Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration
por: Duan, Hongying, et al.
Publicado: (2014)

Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo
por: Fang, Yan, et al.
Publicado: (2022)

Dual effect of aucubin on promoting VEGFR2 mediated angiogenesis and reducing RANKL-induced bone resorption
por: He, Yulin, et al.
Publicado: (2023)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer
por: Lian, Shenyi, et al.
Publicado: (2016)

Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis
por: Min, Li, et al.
Publicado: (2014)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells
por: Yang, Hua, et al.
Publicado: (2010)

Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis
por: Genet, Gael, et al.
Publicado: (2019)

P01.41. Melittin inhibits VEGF-A-induced tumor growth and angiogenesis through blocking VEGFR-2 and COX-2 in allograft tumor model and endothelial cells
por: Huh, J, et al.
Publicado: (2012)

SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
por: Zhou, Huanjiao Jenny, et al.
Publicado: (2018)

Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression
por: Chung, Tae-Wook, et al.
Publicado: (2017)

TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer
por: Zhong, Mengya, et al.
Publicado: (2020)

Tetraspanin18 regulates angiogenesis through VEGFR2 and Notch pathways
por: Li, Grace X., et al.
Publicado: (2021)

Inhibition of Angiogenesis In Vitro by Chebulagic Acid: A COX-LOX Dual Inhibitor
por: Athira, A. P., et al.
Publicado: (2013)

Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen
por: Liu, Caiyun, et al.
Publicado: (2010)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)

Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis
por: JIN, GENGLIN, et al.
Publicado: (2015)

Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion
por: Yang, Yongyong, et al.
Publicado: (2017)

VEGFR1 signaling in retinal angiogenesis and microinflammation
por: Uemura, Akiyoshi, et al.
Publicado: (2021)

Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway
por: Ji, Lijun, et al.
Publicado: (2018)

The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo
por: Zhong, Tangwu, et al.
Publicado: (2020)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
por: Tu, Yingfeng, et al.
Publicado: (2015)

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_edp3av33n7nia5brvh01jid2uf